Scarica l'app Stockscreener
8.49
3.41%
0.28
Dopo l'orario di chiusura:
8.25
-0.24
-2.83%
Precedente Chiudi:
$8.21
Aprire:
$8.07
Volume 24 ore:
858.32K
Relative Volume:
0.58
Capitalizzazione di mercato:
$308.35M
Reddito:
$317.00K
Utile/perdita netta:
$-53.47M
Rapporto P/E:
-4.4921
EPS:
-1.89
Flusso di cassa netto:
$-49.31M
1 W Prestazione:
+54.08%
1M Prestazione:
+161.23%
6M Prestazione:
+458.55%
1 anno Prestazione:
+493.71%
Intervallo 1D:
$7.97
$8.5899
Intervallo di 1 settimana:
$5.465
$9.37
Portata 52W:
$1.10
$9.37
Immuneering Corp Stock (IMRX) Company Profile
Nome
Immuneering Corp
Settore
Industria
Telefono
617-500-8080
Indirizzo
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE
Confronta IMRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMRX
Immuneering Corp
|
8.49 | 338.38M | 317.00K | -53.47M | -49.31M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Immuneering Corp Stock (IMRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-13 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-03-15 | Downgrade | Jefferies | Buy → Hold |
| 2024-03-15 | Reiterato | Needham | Buy |
| 2024-03-15 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-01 | Iniziato | Needham | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-04-19 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-04-19 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-03-30 | Iniziato | Mizuho | Neutral |
| 2023-02-03 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-07-08 | Iniziato | Chardan Capital Markets | Buy |
| 2022-04-01 | Iniziato | Oppenheimer | Outperform |
| 2022-01-07 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Immuneering Corp Borsa (IMRX) Ultime notizie
What MACD and RSI say about Immuneering CorporationTrade Volume Summary & Advanced Technical Analysis Signals - Newser
Will Immuneering Corporation rebound enough to break evenJuly 2025 EndofMonth & Reliable Volume Spike Alerts - Newser
Signal strength of Immuneering Corporation stock in tech scannersWeekly Trend Report & Capital Efficiency Focused Strategies - Newser
What candlestick patterns are forming on Immuneering CorporationTrade Risk Report & Expert Approved Momentum Trade Ideas - Newser
Detecting support and resistance levels for Immuneering Corporation2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
Can Immuneering Corporation recover in the next quarter2025 Analyst Calls & Momentum Based Trading Signals - Newser
Immuneering to announce updated data from Phase 2a trial of Atebimetinib + mGnP - MSN
Volume spikes in Immuneering Corporation stock – what they mean2025 Trading Volume Trends & Daily Chart Pattern Signal Reports - Newser
Published on: 2025-09-11 02:15:14 - Newser
Can trapped investors hope for a rebound in Immuneering Corporation2025 Breakouts & Breakdowns & High Accuracy Swing Trade Signals - Newser
Oppenheimer reiterates Outperform rating on Immuneering stock ahead of data - Investing.com
Immuneering Corporation to Host Investor Call and Present Updated Data at Upcoming Scientific Conferences - Quiver Quantitative
Immuneering to present updated pancreatic cancer survival data - Investing.com
Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25 - GlobeNewswire Inc.
Strategies to average down on Immuneering CorporationWeekly Stock Summary & Smart Money Movement Alerts - Newser
What earnings revisions data tells us about Immuneering CorporationDay Trade & Free Risk Controlled Daily Trade Plans - Newser
How to integrate Immuneering Corporation into portfolio analysis toolsJuly 2025 Closing Moves & Safe Entry Point Identification - Newser
Understanding Immuneering Corporation’s price movementJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - Newser
Backtesting results for Immuneering Corporation trading strategies2025 Support & Resistance & Low Risk High Reward Trade Ideas - Newser
Combining price and volume data for Immuneering CorporationWatch List & Verified Momentum Stock Alerts - Newser
How hedge fund analytics apply to Immuneering Corporation stockEarnings Overview Report & Safe Investment Capital Preservation Plans - Newser
Has Immuneering Corporation found a price floorMarket Performance Summary & Weekly High Conviction Ideas - Newser
Can Immuneering Corporation expand into new marketsEarnings Miss & Growth-Oriented Investment Plans - خودرو بانک
What is the dividend yield of Immuneering CorporationMarket Activity Recap & Weekly Return Optimization Plans - خودرو بانک
Using Python tools to backtest Immuneering Corporation strategiesJuly 2025 Pullbacks & Weekly Top Gainers Alerts - Newser
Tick level data insight on Immuneering Corporation volatilityJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - Newser
Custom watchlist performance reports with Immuneering CorporationTrade Risk Summary & Free Growth Oriented Trading Recommendations - Newser
Aug Reactions: Will Immuneering Corporation stock recover after earningsQuarterly Performance Summary & Technical Confirmation Trade Alerts - خودرو بانک
Can Immuneering Corporation ride the EV waveJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - خودرو بانک
Immuneering Corporation (IMRX) files for up to 9.18M share offering by selling stockholders - StreetInsider
Buyback Watch: Can Immuneering Corporation deliver consistent dividends2025 Growth vs Value & Verified Swing Trading Watchlist - خودرو بانک
Can a trend reversal in Immuneering Corporation lead to recoveryJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Order flow analysis tools used on Immuneering CorporationWeekly Gains Summary & High Conviction Trade Alerts - Newser
Building trade automation scripts for Immuneering CorporationBreakout Watch & Safe Swing Trade Setups - Newser
What momentum shifts mean for Immuneering CorporationRisk Management & Technical Pattern Alert System - Newser
Is Immuneering Corporation a cyclical or defensive stockShort Setup & Growth Oriented Trading Recommendations - خودرو بانک
Does Immuneering Corporation show high probability of reboundShare Buyback & Daily Oversold Bounce Ideas - Newser
Needham & Company LLC Reiterates "Buy" Rating for Immuneering (NASDAQ:IMRX) - MarketBeat
Immuneering Corp Azioni (IMRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):